Regulatory Post Marketing Surveillance Study in Korea
The objective of the study is to investigate and collect post marketing data on the safety and efficacy of Visanne at follow-up visit after about 6 months of treatment and – for a subset of patients – at optional long-term follow-up visit after about 1 year of treatment under daily practice treatment conditions in Korean women and to obtain data on drug utilization on treatment for endometriosis.
- Signed and dated informed consent - Women diagnosed by a physician as having endometriosis - Women who are prescribed Visanne(dienogest 2mg)for the first time during the study period
- All contraindications according to the local marketing authorization have to be considered.
Many Locations, South Korea
E-mail: [email protected]
Phone: +49 30 300139003
Visanne® (dienogest 2mg) Regulatory Post Marketing Surveillance Study in Korea